Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Enax-Krumova

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Schmerz (Berlin, Germany)|February 3, 2016
[Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies]F Petzke, E K Enax-Krumova, W Häuser
Schmerz (Berlin, Germany)|September 8, 2017
F Petzke, E K Enax-Krumova, W Häuser
Schmerz (Berlin, Germany)|June 26, 2023
[Clinical use of botulinum toxin type A in pain medicine]A Schwarzer, T Mäcken, E K Enax-Krumova
European Journal of Pain (London, England)|March 25, 2018
Conditioned pain modulation using painful cutaneous electrical stimulation or simply habituation?L Eitner, Ö S Özgül, E K Enax-Krumova, et al.
European Journal of Pain (London, England)|April 10, 2015
Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic painT Mainka, N M Malewicz, R Baron, et al.
BMC Neuroscience|December 8, 2020
Distraction by a cognitive task has a higher impact on electrophysiological measures compared with conditioned pain modulationA T L Do, E K Enax-Krumova, Ö Özgül, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Schmerz (Berlin, Germany)|February 3, 2016
[Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies]F Petzke, E K Enax-Krumova, W Häuser
Schmerz (Berlin, Germany)|September 8, 2017
F Petzke, E K Enax-Krumova, W Häuser
Schmerz (Berlin, Germany)|June 26, 2023
[Clinical use of botulinum toxin type A in pain medicine]A Schwarzer, T Mäcken, E K Enax-Krumova
European Journal of Pain (London, England)|March 25, 2018
Conditioned pain modulation using painful cutaneous electrical stimulation or simply habituation?L Eitner, Ö S Özgül, E K Enax-Krumova, et al.
European Journal of Pain (London, England)|April 10, 2015
Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic painT Mainka, N M Malewicz, R Baron, et al.
BMC Neuroscience|December 8, 2020
Distraction by a cognitive task has a higher impact on electrophysiological measures compared with conditioned pain modulationA T L Do, E K Enax-Krumova, Ö Özgül, et al.
Pageof 1